LP352 not checked

Longboard Pharmaceuticals

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
5 in total · 3 in the EU
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“LP352 will be administered orally or through G-tube/ percutaneous endoscopic gastrostomy (PEG) tube”In the company’s words, NCT06719141 on ClinicalTrials.gov
Tested for
Developmental and Epileptic Encephalopathy (2 trials), Dravet Syndrome
Main trialPhase 3
“This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.”In the company’s words, NCT06719141 on ClinicalTrials.gov
Other names
Bexicaserin

Other drugs for Developmental and Epileptic Encephalopathy

All 20 drugs for Developmental and Epileptic Encephalopathy

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials5

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 31 Oct 2026 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
Phase 3Active, not recruiting 31 Dec 2026 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3Enrolling by invitation 11 Nov 2027 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Phase 2Completed 20 Dec 2024 Open-label, Long-term Safety Study of LP352 in Subjects With Developmental and Epileptic Encephalopathy
Phase 1/2Completed 16 Nov 2023 Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow LP352

Following is part of Solo: you see every change to LP352 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in